PURCHASE AND SALE AGREEMENT by and among Endo Enterprise, Inc., Endo USA, Inc. and Paladin Pharma Inc. as the Buyers and Endo International plc and the other Sellers (as defined herein), as the Sellers Dated as of April 14, 2024Purchase and Sale Agreement • April 18th, 2024 • Endo International PLC • Pharmaceutical preparations • New York
This PURCHASE AND SALE AGREEMENT, dated as of April 14, 2024 (this “Agreement”), is made by and among Endo International plc, a public limited company incorporated in Ireland (“Seller Parent”), each of the other Sellers (as defined below), Endo Enterprise, Inc., a Delaware corporation (the “Enterprise Buyer”), Endo USA, Inc., a Delaware corporation (the “US Buyer”), and Paladin Pharma Inc., a corporation incorporated under the laws of Canada (the “Canada Buyer” and, together with the Enterprise Buyer, the US Buyer and, solely if Buyer Parent duly exercises the Canada Holdco Equity Option in accordance with Section 2.8(a) below, the Canada HoldCo Equity Buyer, each a “Buyer” and, collectively, the “Buyers”).
